PTC Therapeutics, Inc. Increase (Decrease) in Receivables
PTC Therapeutics, Inc. (PTCT) reported Increase (Decrease) in Receivables of $60.12 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInReceivables · last filed 2026-07-30
- PTC Therapeutics, Inc. increase (decrease) in receivables for the quarter ending 2026-06-30 was $19.73M.
- PTC Therapeutics, Inc. increase (decrease) in receivables for the quarter ending 2026-03-31 was $40.39M, a 15.49% decline year-over-year.
- PTC Therapeutics, Inc. increase (decrease) in receivables for the quarter ending 2025-12-31 was -$22.21M.
- PTC Therapeutics, Inc. increase (decrease) in receivables for the quarter ending 2025-09-30 was $6.47M, a 16.13% decline year-over-year.
- PTC Therapeutics, Inc. increase (decrease) in receivables for fiscal 2025 was $10.15M.
- PTC Therapeutics, Inc. increase (decrease) in receivables for fiscal 2024 was -$1.73M, a 212.54% decline from fiscal 2023.
- PTC Therapeutics, Inc. increase (decrease) in receivables for fiscal 2023 was $1.54M, a 96.82% decline from fiscal 2022.
- PTC Therapeutics, Inc. increase (decrease) in receivables for fiscal 2022 was $48.47M, a 7.73% increase from fiscal 2021.
| Period end | Increase (Decrease) in Receivables 3 month | Increase (Decrease) in Receivables 6 month | Increase (Decrease) in Receivables 6 month as first filed | Increase (Decrease) in Receivables 9 month | Increase (Decrease) in Receivables 9 month as first filed | Increase (Decrease) in Receivables 12 month | Increase (Decrease) in Receivables 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $19.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $60.12M 10-Q · filed 2026-07-30 | $37.90M derived: sum of 3 quarters · filed 2026-07-30 | $44.38M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2026-03-31 | $40.39M 10-Q · filed 2026-05-07 | $18.18M derived: sum of 2 quarters · filed 2026-05-07 | $24.65M derived: sum of 3 quarters · filed 2026-05-07 | $2.75M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-12-31 | -$22.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$15.74M derived: sum of 2 quarters · filed 2026-02-19 | -$37.64M derived: sum of 3 quarters · filed 2026-07-30 | $10.15M 10-K · filed 2026-02-19 | |||
| 2025-09-30 | $6.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$15.43M derived: sum of 2 quarters · filed 2026-07-30 | $32.37M 10-Q · filed 2025-11-04 | -$8.40M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-06-30 | -$21.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $25.89M 10-Q · filed 2026-07-30 | -$14.87M derived: sum of 3 quarters · filed 2026-07-30 | -$7.15M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-03-31 | $47.79M 10-Q · filed 2026-05-07 | $7.03M derived: sum of 2 quarters · filed 2026-05-07 | $14.75M derived: sum of 3 quarters · filed 2026-05-07 | $6.56M derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | -$40.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$33.04M derived: sum of 2 quarters · filed 2026-02-19 | -$41.23M derived: sum of 3 quarters · filed 2026-02-19 | -$1.73M 10-K · filed 2026-02-19 | |||
| 2024-09-30 | $7.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$471.00K derived: sum of 2 quarters · filed 2025-11-04 | $39.03M 10-Q · filed 2025-11-04 | $30.68M derived: sum of 4 quarters · filed 2026-02-19 | |||
| 2024-06-30 | -$8.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $31.31M 10-Q · filed 2025-08-07 | $22.96M derived: sum of 3 quarters · filed 2026-02-19 | $14.83M derived: sum of 4 quarters · filed 2026-02-19 | |||
| 2024-03-31 | $39.50M 10-Q · filed 2025-05-06 | $31.15M derived: sum of 2 quarters · filed 2026-02-19 | $23.02M derived: sum of 3 quarters · filed 2026-02-19 | -$2.39M derived: sum of 4 quarters · filed 2026-02-19 | |||
| 2023-12-31 | -$8.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$16.48M derived: sum of 2 quarters · filed 2026-02-19 | -$41.89M derived: sum of 3 quarters · filed 2026-02-19 | $1.54M 10-K · filed 2026-02-19 | |||
| 2023-09-30 | -$8.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$33.54M derived: sum of 2 quarters · filed 2024-11-07 | $9.89M 10-Q · filed 2024-11-07 | $33.58M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-06-30 | -$25.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $18.02M 10-Q · filed 2024-08-08 | $41.72M derived: sum of 3 quarters · filed 2025-02-27 | $36.94M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-03-31 | $43.43M 10-Q · filed 2024-04-25 | $67.12M derived: sum of 2 quarters · filed 2025-02-27 | $62.34M derived: sum of 3 quarters · filed 2025-02-27 | $63.52M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2022-12-31 | $23.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $18.92M derived: sum of 2 quarters · filed 2025-02-27 | $20.10M derived: sum of 3 quarters · filed 2025-02-27 | $48.47M 10-K · filed 2025-02-27 | |||
| 2022-09-30 | -$4.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | -$3.60M derived: sum of 2 quarters · filed 2023-10-26 | $24.77M 10-Q · filed 2023-10-26 | $41.14M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-06-30 | $1.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $29.55M 10-Q · filed 2023-08-03 | $45.91M derived: sum of 3 quarters · filed 2024-02-29 | $65.12M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-03-31 | $28.37M 10-Q · filed 2023-04-27 | $44.74M derived: sum of 2 quarters · filed 2024-02-29 | $63.94M derived: sum of 3 quarters · filed 2024-02-29 | $48.35M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2021-12-31 | $16.37M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $35.57M derived: sum of 2 quarters · filed 2024-02-29 | $19.98M derived: sum of 3 quarters · filed 2024-02-29 | $44.99M 10-K · filed 2024-02-29 | |||
| 2021-09-30 | $19.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $3.62M derived: sum of 2 quarters · filed 2022-10-27 | $28.63M 10-Q · filed 2022-10-27 | $39.23M derived: sum of 4 quarters · filed 2023-02-21 | |||
| 2021-06-30 | -$15.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $9.42M 10-Q · filed 2022-08-04 | $20.02M derived: sum of 3 quarters · filed 2023-02-21 | $21.76M derived: sum of 4 quarters · filed 2023-02-21 | |||
| 2021-03-31 | $25.01M 10-Q · filed 2022-05-03 | $35.61M derived: sum of 2 quarters · filed 2023-02-21 | $37.35M derived: sum of 3 quarters · filed 2023-02-21 | $37.84M derived: sum of 4 quarters · filed 2023-02-21 | |||
| 2020-12-31 | $10.60M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $12.34M derived: sum of 2 quarters · filed 2023-02-21 | $12.83M derived: sum of 3 quarters · filed 2023-02-21 | $10.48M 10-K · filed 2023-02-21 | |||
| 2020-09-30 | $1.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $2.23M derived: sum of 2 quarters · filed 2021-10-28 | -$121.00K 10-Q · filed 2021-10-28 | -$5.77M derived: sum of 4 quarters · filed 2022-02-22 | |||
| 2020-06-30 | $486.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | -$1.86M 10-Q · filed 2021-07-29 | -$7.51M derived: sum of 3 quarters · filed 2022-02-22 | -$23.09M derived: sum of 4 quarters · filed 2022-02-22 | |||
| 2020-03-31 | -$2.35M 10-Q · filed 2021-05-04 | -$7.99M derived: sum of 2 quarters · filed 2022-02-22 | -$23.57M derived: sum of 3 quarters · filed 2022-02-22 | $6.92M derived: sum of 4 quarters · filed 2022-02-22 | |||
| 2019-12-31 | -$5.65M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | -$21.23M derived: sum of 2 quarters · filed 2022-02-22 | $9.26M derived: sum of 3 quarters · filed 2022-02-22 | -$11.53M 10-K · filed 2022-02-22 | |||
| 2019-09-30 | -$15.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $14.91M derived: sum of 2 quarters · filed 2020-10-29 | -$5.88M 10-Q · filed 2020-10-29 | $21.03M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2019-06-30 | $30.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $9.70M 10-Q · filed 2020-08-05 | $36.61M derived: sum of 3 quarters · filed 2021-02-25 | $18.86M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2019-03-31 | -$20.79M 10-Q · filed 2020-04-30 | $6.12M derived: sum of 2 quarters · filed 2021-02-25 | -$11.63M derived: sum of 3 quarters · filed 2021-02-25 | $4.58M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2018-12-31 | $26.91M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $9.16M derived: sum of 2 quarters · filed 2021-02-25 | $25.37M derived: sum of 3 quarters · filed 2021-02-25 | $29.59M 10-K · filed 2021-02-25 | |||
| 2018-09-30 | -$17.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | -$1.54M derived: sum of 2 quarters · filed 2019-10-30 | $2.68M 10-Q · filed 2019-10-30 | $3.89M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2018-06-30 | $16.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $20.43M 10-Q · filed 2019-08-06 | $21.64M derived: sum of 3 quarters · filed 2020-03-02 | $25.87M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2018-03-31 | $4.22M 10-Q · filed 2019-05-02 | $5.43M derived: sum of 2 quarters · filed 2020-03-02 | $9.66M derived: sum of 3 quarters · filed 2020-03-02 | $9.68M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2017-12-31 | $1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $5.44M derived: sum of 2 quarters · filed 2020-03-02 | $5.46M derived: sum of 3 quarters · filed 2020-03-02 | $12.20M 10-K · filed 2020-03-02 | |||
| 2017-09-30 | $4.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $4.25M derived: sum of 2 quarters · filed 2018-11-05 | $10.99M 10-Q · filed 2018-11-05 | $9.80M derived: sum of 4 quarters · filed 2019-03-01 | |||
| 2017-06-30 | $16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $6.76M 10-Q · filed 2018-08-07 | $5.57M derived: sum of 3 quarters · filed 2019-03-01 | $13.12M derived: sum of 4 quarters · filed 2019-03-01 | |||
| 2017-03-31 | $6.75M 10-Q · filed 2018-05-09 | $5.55M derived: sum of 2 quarters · filed 2019-03-01 | $13.11M derived: sum of 3 quarters · filed 2019-03-01 | $10.91M derived: sum of 4 quarters · filed 2019-03-01 | |||
| 2016-12-31 | -$1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $6.36M derived: sum of 2 quarters · filed 2019-03-01 | $4.16M derived: sum of 3 quarters · filed 2019-03-01 | $14.84M 10-K · filed 2019-03-01 | |||
| 2016-09-30 | $7.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $5.36M derived: sum of 2 quarters · filed 2017-11-02 | $16.04M 10-Q · filed 2017-11-02 | $19.36M derived: sum of 4 quarters · filed 2018-03-06 | |||
| 2016-06-30 | -$2.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $8.48M 10-Q · filed 2017-08-09 | $11.80M derived: sum of 3 quarters · filed 2018-03-06 | $14.72M derived: sum of 4 quarters · filed 2018-03-06 | |||
| 2016-03-31 | $10.68M 10-Q · filed 2017-05-08 | $14.00M derived: sum of 2 quarters · filed 2018-03-06 | $16.92M derived: sum of 3 quarters · filed 2018-03-06 | $18.85M derived: sum of 4 quarters · filed 2018-03-06 | |||
| 2015-12-31 | $3.33M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | $6.24M derived: sum of 2 quarters · filed 2018-03-06 | $8.17M derived: sum of 3 quarters · filed 2018-03-06 | $6.91M 10-K · filed 2018-03-06 | |||
| 2015-09-30 | $2.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $4.85M derived: sum of 2 quarters · filed 2016-11-03 | $3.58M 10-Q · filed 2016-11-03 | $6.73M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2015-06-30 | $1.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $669.00K 10-Q · filed 2016-08-04 | $3.82M derived: sum of 3 quarters · filed 2017-03-16 | $4.26M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2015-03-31 | -$1.27M 10-Q · filed 2016-05-05 | $1.88M derived: sum of 2 quarters · filed 2017-03-16 | $2.32M derived: sum of 3 quarters · filed 2017-03-16 | $2.34M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2014-12-31 | $3.15M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $3.59M derived: sum of 2 quarters · filed 2017-03-16 | $3.61M derived: sum of 3 quarters · filed 2017-03-16 | $3.49M 10-K · filed 2017-03-16 | |||
| 2014-09-30 | $438.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $458.00K derived: sum of 2 quarters · filed 2015-11-09 | $338.00K 10-Q · filed 2015-11-09 | $512.00K derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-06-30 | $20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31 | -$100.00K 10-Q · filed 2015-07-31 | $74.00K derived: sum of 3 quarters · filed 2016-02-29 | -$13.00K derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-03-31 | -$120.00K 10-Q · filed 2015-05-05 | $54.00K derived: sum of 2 quarters · filed 2016-02-29 | -$33.00K derived: sum of 3 quarters · filed 2016-02-29 | -$108.00K derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2013-12-31 | $174.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $87.00K derived: sum of 2 quarters · filed 2016-02-29 | $12.00K derived: sum of 3 quarters · filed 2016-02-29 | -$56.00K 10-K · filed 2016-02-29 | -$56.09K 10-K · filed 2014-03-06 | ||
| 2013-09-30 | -$87.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$162.00K derived: sum of 2 quarters · filed 2014-11-06 | -$230.00K 10-Q · filed 2014-11-06 | -$229.96K 10-Q · filed 2013-11-14 | -$384.30K derived: sum of 4 quarters · filed 2015-03-02 | ||
| 2013-06-30 | -$75.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$143.00K 10-Q · filed 2014-08-07 | -$143.17K 10-Q · filed 2013-08-13 | -$297.30K derived: sum of 3 quarters · filed 2015-03-02 | -$446.89K derived: sum of 4 quarters · filed 2015-03-02 | ||
| 2013-03-31 | -$68.00K 10-Q · filed 2014-05-06 | -$222.30K derived: sum of 2 quarters · filed 2015-03-02 | -$371.89K derived: sum of 3 quarters · filed 2015-03-02 | ||||
| 2012-12-31 | -$154.30K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | -$303.89K derived: sum of 2 quarters · filed 2015-03-02 | -$230.00K 10-K · filed 2015-03-02 | -$230.31K 10-K · filed 2014-03-06 | |||
| 2012-09-30 | -$149.59K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$75.70K 10-Q · filed 2013-11-14 | |||||
| 2012-06-30 | $73.89K 10-Q · filed 2013-08-13 | ||||||
| 2011-12-31 | -$2.05M 10-K · filed 2014-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |